depemokimab

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

Mechanism of action

More general terms

References

  1. Jackson DJ et al Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype. N Engl J Med 2024. Sept 9 PMID: https://www.ncbi.nlm.nih.gov/pubmed/39248309 https://www.nejm.org/doi/full/10.1056/NEJMoa2406673